In this paradigm, the aberrant accumulation of Id2 and the subsequent E-cadherin down-regulation as we described should provide a selective growth advantage in the tumor microenvironment by increasing the probability of invasion and metastasis. This evidence concerns the gene ID2 and neoplasm.